Keyphrases
Ablation
8%
Adjusted Hazard Ratio
13%
Adult Congenital Heart Disease
7%
Arrhythmia
6%
Biventricular Pacing
6%
Cardiac Implantable Electronic Device
10%
Cardiac Mortality
8%
Cardiac Resynchronization Therapy
100%
Cardiomyopathy
6%
Cardiovascular Magnetic Resonance
35%
Cardiovascular Mortality
6%
Clinical Outcomes
16%
Confidence Interval
27%
CRT-D
6%
Defibrillation
13%
Device Implantation
5%
Device Therapy
5%
Dyssynchrony
8%
European Heart Rhythm Association
10%
Fabry
5%
Fabry Cardiomyopathy
6%
Fabry Disease
8%
Feature Tracking
8%
Fibrosis
14%
Hazard Ratio
11%
Heart Failure
14%
Heart Failure Hospitalization
13%
Heart Failure Patients
7%
Heart Tissue
5%
Hemodynamic Effects
8%
Hospitalization
7%
Hypertrophic Cardiomyopathy
5%
Implantable Defibrillator
13%
Left Ventricular Ejection Fraction
20%
Left Ventricular Function
20%
Left Ventricular Lead
19%
Long-term Clinical Outcome
6%
Multipoint Pacing
8%
Myocardial Fibrosis
11%
Myocardial Scar
11%
Nonischemic Cardiomyopathy
14%
Pacemaker
7%
Patients with Coronary Artery Disease
6%
Patients with Heart Failure
22%
QRS Duration
16%
Randomized Controlled Trial
6%
Scar
11%
Sudden Cardiac Death
24%
Total Mortality
20%
Ventricular Arrhythmia
20%
Medicine and Dentistry
Adult Congenital Heart Disease
5%
Atrial Fibrillation
6%
Cardiac Magnetic Resonance Imaging
34%
Cardiac Resynchronization Therapy
97%
Cardiovascular System
7%
Congestive Heart Failure
53%
Coronary Artery Disease
5%
Coronary Sinus
6%
Defibrillation
11%
Defibrillator
6%
Diagnosis
5%
Electrocardiogram
5%
Fabry Disease
6%
Fibrosis
8%
Gadolinium
5%
Hazard Ratio
21%
Heart Left Ventricle Ejection Fraction
13%
Heart Left Ventricle Function
5%
Heart Pacing
5%
Heart Rhythm
10%
Heart Tissue
5%
Heart Ventricle Arrhythmia
12%
Hemodynamic
11%
Hypertrophic Cardiomyopathy
5%
Implant
5%
Implantable Automatic Defibrillator
17%
Ischemic Cardiomyopathy
5%
Laser Doppler Flowmetry
5%
Left Bundle Branch Block
8%
Left Ventricular Leads
11%
Left Ventricular Pacing
12%
Meta-Analysis
5%
Myocardial Disease
7%
New York Heart Association Class
9%
Nonischemic Cardiomyopathy
14%
Pacemaker Implantation
5%
Patient Referral
6%
Pulse Rate
5%
QRS Interval
17%
Randomized Controlled Trial
8%
Risk Stratification
5%
Sudden Cardiac Death
20%
Systematic Review
6%
